Msn Life Sciences Private Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is HALOPERIDOL USP, with a corresponding US DMF Number 33692.
Remarkably, this DMF maintains an Active status since its submission on March 26, 2019, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of November 18, 2019, and payment made on September 25, 2019, indicating their dedication to facilitating drug approvals, Categorized as Type II